Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (19234)	3/30/2004 1:45:26 PM
From: GARY P GROBBEL	Read Replies (3) \| Respond to of 120405

(BSNS WIRE) Emergency Filtration Products Announces 2003 Results Emergency Filtration Products Announces 2003 Results Health/Medical Writers / Business Editors HENDERSON, Nev.--(BUSINESS WIRE)--EMFP-- Emergency Filtration Products Inc. (EFP) (OTCBB: EMFP) reported that revenues rose 194% to $764,025 for the period ended Dec. 31, 2003, compared to $260,215 for the year ended Dec. 31, 2002. For the year ended Dec. 31, 2003 and 2002, the company reported net losses of ($706,455) ($0.03 per share) and ($1,140,667) ($0.08 per share), respectively. The rise in revenues was attributable to substantial increases in U.S. military orders during 2003 due to ongoing international conflicts throughout the world. The company is also focusing its marketing and sales efforts on non-military markets, in an effort to increase revenues in order to attain profitability. After a number of production delays caused by materials shortages, product redesign efforts and other factors, the company and its Taiwanese partner, Weise Labs Inc., have been producing Nano masks and associated filters as well as actively marketing the NanoMask. "Production delays associated with producing large volumes of our NanoMask, along with delays in selecting the best distributors for this product, caused us to miss our sales targets for 2003," said Doug Beplate, president, EFP. "However, we believe our sales efforts will yield substantial sales contracts in the near future, which will prove that our faith in NanoMask's sales potential was well founded. Moreover, we are planning an expansion of our Taiwanese production facility to produce a host of other EFP products, including: Series One Breathing Circuit Filters, RespAide CPR Isolation Mask and Vapor Isolation Valve, that will be sold into Asian and other international markets." Beplate went on to add, "As a result of these developments and continuing strong indications of interest in our products from a number of international medical products distributors, I believe that EFP is poised to enjoy significant revenue gains in 2004 and beyond." About Emergency Filtration Products Inc. EFP is an air filtration products manufacturer whose technology provides filtration efficiencies of "greater than 99.99% at a particle size of 0.027 microns." Its initial products were developed for the medical market: the Vapor Isolation Valve(TM); RespAide -- a CPR mask used for resuscitation of respiratory/cardiac arrest cases; an A.E.D. prep kit; and the 2H Breathing Circuit Filter. Each has received FDA approval. EFP's 2H NanoMask with 27 nanometers filtration capability relies on the company's core 2H Technology(TM) filtration system, which utilizes a combination of hydrophobic and hydrophilic filters able to capture and isolate bacterial and viral microorganisms with efficiencies of 99.99%. The environmental mask utilizes the company's patented 2H Technology(TM) and nano-technology to enhance the capture-and-isolation characteristics of the filter media. In addition to filtration products, the company also supplies Superstat, a modified hemostatic collagen, to the medical market and U.S. military for extreme wound care. Forward-Looking Statements This release may contain statements that are forward looking. With the exception of historical information, the matters discussed in this news release are "forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. The actual future results of the company could differ significantly from those statements. Specifically, potential future sales for existing products depend on the execution of sales contacts that have not been consummated. In addition, the expansion of our production facility and the proposed sales of additional products may be subject to financing constraints and the success of planned marketing campaigns. Emergency Filtration does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. KEYWORD: INTERNATIONAL ASIA PACIFIC NEVADA INDUSTRY KEYWORD: MEDICAL DEVICES GOVERNMENT AEROSPACE/DEFENSE EARNINGS SOURCE: Emergency Filtration Products Inc. CONTACT INFORMATION: Emergency Filtration Products Inc., Henderson Wendy Harper, 702-558-5164 Fax: 702-567-1893 contactus@emergencyfiltration.com www.emergencyfiltration.com or WPH Consultants Ltd. Investor Relations Philippe Niemetz 800-477-7570 or 212-344-6464 philippe.niemetz@wphconsultants.com * end of story *